Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1280
In December 2017, Camber Spine announced that this company has received U.S. Food and
Drug Administration (FDA) clearance to market its SPIRA-C, Open Matrix Cervical Interbody
device. This clearance marks Camber's second implant clearance in the SPIRA family of implant
systems to be released in the U.S. market, indicated for use at one or two contiguous levels in
the cervical spine, in skeletally mature patients who have had six weeks of non-operative
treatment for the degenerative disk disease (DDD) with up to Grade 1 spondylolisthesis.
Furthermore, the Spinal Kinetics, Inc., the designer and manufacturer of the M6 artificial disc,
announced in June 2017, that the total implantations of the company’s M6-C Cervical and M6-L
Lumbar discs have exceeded 50,000 throughout the international markets where the M6 is
commercially available. This fact supports the growing demand of degenerative disc disease
treatment market.
Key players operating in the global degenerative disc disease treatment market includes
Medtronic Plc, Zimmer Biomet, Paradigm Spine, Globus Medical, Cousin Biotech, Ulrich Medical
and SpineVision.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com